# Lupin Ltd (LUPIN)
> Exchange: NSE | Sector: Pharma | ISIN: INE326A01037

## Price
Current Price: ₹2287.2
Day Change: +0.24%
52W High: ₹2298.3
52W Low: ₹1774
Market Cap: ₹1,03,910 Cr

## Valuation
P/E: 24.1
P/B: 5.29
EPS: ₹94.37
Book Value: ₹491.29
Dividend Yield: 0.8%

## Returns
1Y Return: 11.03%

## Profitability
ROE: 26.91%
ROCE: 24.58%
Debt/Equity: 0.29
Revenue Growth: 31.9%
Profit Growth: 89%
EBITDA Margin: 29.19%
Operating Margin: 24.24%

## About
Lupin Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Lupin Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript
- BSE Filing: Announcement under Regulation 30 (LODR)-Press Release / Media Release

## Access
Current tier: anonymous
More history: Register free to see 8 more years.

## Data Freshness
Quote Updated: 2026-05-25T18:00:11.510Z
Price History Updated: 2026-05-25T05:29:11.416Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:29:11.416Z
Quant Updated: 2026-05-25T05:29:11.416Z
Sentiment Updated: 2026-05-25T05:29:11.416Z
Financials Status: current
Financials Updated: 2026-05-18T02:34:29.653Z
Financials Last Attempt: 2026-05-18T02:34:29.653Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2016)
Revenue: ₹12770 Cr
Operating Profit: ₹3624 Cr (OPM 28%)
Net Profit: ₹2444 Cr
Tax: ₹3415 Cr

## Annual P&L History
Mar 2016: Rev ₹12770Cr | PAT ₹2444Cr | OPM 28%
Mar 2017: Rev ₹14256Cr | PAT ₹2270Cr | OPM 26%
Mar 2018: Rev ₹17367Cr | PAT ₹2565Cr | OPM 26%

## Balance Sheet (Mar 2016)
Total Assets: ₹13054 Cr
Total Liabilities: ₹13054 Cr
Borrowings: ₹537 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Vinita D. Gupta, CEO & Executive Director
- Ramesh  Swaminathan, Executive Director, Global CFO, CRO & Head of API Plus SBU and IT
- Nilesh Deshbandhu Gupta, MD & Executive Director
- Christoph  Funke, Chief Technical Operations Officer
- Shahin  Fesharaki, Chief Scientific Officer

---
Source: rupiya.io/stocks/lupin
Disclaimer: For research and education only. Not investment advice.